Lataa...
Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage
SUMMARY: We compared the patterns of osteoporosis medication prescribing between two provinces in Canada with different public drug coverage policies. Oral bisphosphonates were the primary drugs used, yet access to the second-generation oral bisphosphonates (alendronate, risedronate) was limited in...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer-Verlag
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304053/ https://ncbi.nlm.nih.gov/pubmed/21901476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-011-1771-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|